Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Lichterfeld

Showing results (111-120 of 168) with videos related to

Pageof 17
Sort By:
JCI Insight|February 1, 2017
Circulating CXCR5<sup>+</sup>CXCR3<sup>+</sup>PD-1<sup>lo</sup> Tfh-like cells in HIV-1 controllers with neutralizing antibody breadthEnrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, et al.
Nature Communications|September 9, 2016
Broad activation of latent HIV-1 in vivoKirston Barton, Bonnie Hiener, Anni Winckelmann, et al.
The Journal of Clinical Investigation|June 20, 2017
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cellsGuinevere Q Lee, Nina Orlova-Fink, Kevin Einkauf, et al.
Nature|December 1, 2025
CD8<sup>+</sup> T cell stemness precedes post-intervention control of HIV viremiaZahra Kiani, Jonathan M Urbach, Hannah Wisner, et al.
AIDS (London, England)|April 2, 2019
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individualsLine K Vibholm, Christina V Konrad, Mariane H Schleimann, et al.
Science Translational Medicine|December 15, 2021
Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllersXiaodong Lian, Ce Gao, Xiaoming Sun, et al.
AIDS (London, England)|November 26, 2024
Differential immunophenotype and proviral composition in young adults with perinatally acquired HIVLucia Baquero, Sofia Stover, Marie Armani-Tourret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2025
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo StudyGbolahan Ajibola, Bryan S Nelson, Aischa Niesar, et al.
Plos Medicine|November 2, 2006
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1Marcus Altfeld, Elizabeth T Kalife, Ying Qi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus ControllersJonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Pageof 17

Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
JCI Insight|February 1, 2017
Circulating CXCR5<sup>+</sup>CXCR3<sup>+</sup>PD-1<sup>lo</sup> Tfh-like cells in HIV-1 controllers with neutralizing antibody breadthEnrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, et al.
Nature Communications|September 9, 2016
Broad activation of latent HIV-1 in vivoKirston Barton, Bonnie Hiener, Anni Winckelmann, et al.
The Journal of Clinical Investigation|June 20, 2017
Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cellsGuinevere Q Lee, Nina Orlova-Fink, Kevin Einkauf, et al.
Nature|December 1, 2025
CD8<sup>+</sup> T cell stemness precedes post-intervention control of HIV viremiaZahra Kiani, Jonathan M Urbach, Hannah Wisner, et al.
AIDS (London, England)|April 2, 2019
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individualsLine K Vibholm, Christina V Konrad, Mariane H Schleimann, et al.
Science Translational Medicine|December 15, 2021
Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllersXiaodong Lian, Ce Gao, Xiaoming Sun, et al.
AIDS (London, England)|November 26, 2024
Differential immunophenotype and proviral composition in young adults with perinatally acquired HIVLucia Baquero, Sofia Stover, Marie Armani-Tourret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2025
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo StudyGbolahan Ajibola, Bryan S Nelson, Aischa Niesar, et al.
Plos Medicine|November 2, 2006
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1Marcus Altfeld, Elizabeth T Kalife, Ying Qi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2019
Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus ControllersJonathan Z Li, Florencia P Segal, Ronald J Bosch, et al.
Pageof 17